Lois Jane Heller, Ph.D. - MED - Duluth, University of Minnesota
Gold University of Minnesota M. Skip to main content.University of Minnesota.
Driven to Discover.
Academic Health Center Duluth
What's Inside


Medical School Duluth Home

Calendar

First Year

Second Year

2-Up Calendar


Medical School, Twin Cities

 
Search

  Home > Faculty > Lois Jane Heller, Ph.D.
 

Lois Jane Heller, Ph.D.


bio pic
Contact Information

Phone: 218-726-7905
Fax: 218-726-6356

Email:

lheller@d.umn.edu

Address:

355 SMed
1035 University Drive
Duluth, MN  55812


http://www.med.umn.edu/duluth



Professor

Research

General research interests include influences of various pathophysiological conditions upon cardiac function.  Specific current interests and projects include studies of the effects of healthy aging upon cardiovascular reflexes, role of gender and genetic predisposition to cardiovascular disease upon development of cardiac failure.

Education

1964 - BA degree (Biology and Chemistry), Albion College, Albion, MI

1966 - MS degree (Physiology), University of Michigan, Ann Arbor, MI

1970 - PhD degree (Physiology), University of Illinois Medical Center, Chicago, IL

Teaching

  • Cardiovascular Physiology (Meds)
  • Gastro-Intestinal Physiology (Meds)
  • Undergrad/grad teaching in Phsl 3011, Phsl 5601, Phsl 5602, Phsl 8401
  • Course Director for Gastro-Intestinal Hepato-Biliary Medicine Course (Med)
  • Course Director for Phsl 3011 (Undergrad Physiology Course)
  • Course Director for Phsl 8401

Publications


Textbook

D. E. Mohrman and L. J. Heller. Cardiovascular Physiology. McGraw-Hill Book Company, New York, Sixth Edition, 2006. ( A textbook for medical and allied health students)

Recent Peer-Reviewed Manuscripts

Solem, L. E., L. J. Heller, and K. B. Wallace. Dose-dependent induction of cardiac mitochondrial calcium cycling and cell killing by adriamycin. J. Mol. Cell. Cardiol. 28:1023-1032, 1996.

Lear, P. M., L. J. Heller, and J. R. Prohaska. Cardiac hypertrophy in copper-deficient rats is not attenuated by angiotensin II receptor antagonist L-158,809. Proc. Soc. Exp. Biol. Med.212:284-292, 1996.

Heller, L. J., J. A. Opsahl, S. E. Wernsing, R. Saxena and S. A. Katz. Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy. Am J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R849-856, 1998.

Heller, L. J. and D. E. Mohrman. Comparison of blood pressure responses to intra-arterial and intra-venous injections of angiotensin I, angiotensin II and bradykinin. Life Sciences 62: PL 121-125, 1998.

Prohaska, J. R. and L. J Heller. Calcium reintroduction decreases viability of cardiac myocytes from copper-deficient rats. J. Nutr. 129:1842-1845, 1999.

Heller, L. J. and S. A. Katz. Influence of enalapril on established pressure-overload cardiac hypertrophy in low and normal renin states in female rats. Life Sciences 66:1423-1433, 2000

Katz, S. A., J. A. Opsahl, S. E. Wernsing, L. M. Forbis, J. Smith and L. J. Heller. Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 278:R578-R586, 2000.

Heller, L. J., D. E. Mohrman and J. R. Prohaska. Decreased passive stiffness of cardiac myocytes and cardiac tissue from copper-deficient rat hearts. Am. J. Physiol. Heart Circ Physiol 278: H1840-1847 2000.

Adams, A. and L. J. Heller. Production of high-titer stocks of the English strain of rat cytomegalovirus. J. Virological Methods 86:173-177, 2000.

Zhou, S. , L. J. Heller and K. B. Wallace. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. Toxicol. and Appl. Pharmacol. 175:60-67, 2001

Heller, L. J., D. E. Mohrman, J. A. Smith and K. B. Wallace. Multi-track system for superfusing isolated cardiac myocytes. Am. J. Physiol. Heart Circ Physiol 284: H1872-1878, 2003

Recent Published Abstracts

Heller, L. J., J. A. Smith, D. E. Mohrman and K. B. Wallace. A simple method for simulating ischemia and reperfusion conditions in isolated cardiac myocytes. FASEB J. 14:A683, 2000.

Heller, L. J., D. E. Mohrman and K.B. Wallace. Effects of simulated ischemia and reperfusion on cardiac myocytes isolated from adriamycin-treated rats. FASEB J 15: A766, 2001.

Heller, L. J., J. N. Denninger and K. B. Wallace. Responses of isolated hearts from adriamycin-treated rats to global ischemia and reperfusion. FASEB J 16:A858, 2002.

Heller, L. J., K. Stephenson, J. Denninger and K. B. Wallace. Reduced cold tolerance of cardiac myocytes isolated from adriamycin-treated rats. FASEB J 17: A518, 2003.

Heller, L. J., E. Hermanson, A Siders, J. A. Bjork and K. B. Wallace. Cardiac and hepatic antioxidant enzyme activity following chronic adriamycin treatment. FASEB J 17: A880, 2003.

Heller, L. J., and J. N. Denninger. Pyruvate + iodoacetate attenuates cardiotoxic effect of cyanide on isolated rat hearts. FASEB J 18: A1005-6, 2004.

Heller, L. J. and P. A. Lennox. Age-dependent blunting of the heart rate component of reflex adjustments to postural changes does not compromise blood pressure control. FASEB J 19:LB 46, 2005.

Fettig, P, A Tobias, L Heller, F Apple and L. Sharkey. Genetic predisposition to cardiovascular disease potentiates delayed doxorubicin cardiotoxicity during pregnancy. FASEB J 20: in press, 2006


Feedback | Notice of Privacy Practices